ClinVar Miner

Submissions for variant NM_005518.4(HMGCS2):c.1153T>A (p.Ser385Thr)

gnomAD frequency: 0.00015  dbSNP: rs4716
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001901355 SCV002175863 uncertain significance 3-hydroxy-3-methylglutaryl-CoA synthase deficiency 2021-11-27 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 385 of the HMGCS2 protein (p.Ser385Thr). This variant is present in population databases (rs4716, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with HMGCS2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.